Biliary Cancer clinical trials

Explore recruiting biliary cancer clinical trials.

Recruiting biliary cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Biliary Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

SAFIR ABC10 : Molecular targeted maintenance therapy versus standard of care in advanced biliary cancer: an international, randomised, controlled, open-label, platform phase 3 trial

France, Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

SEVILLA_A randomised, phase II trial to evaluate the efficacy of ivonescimab, a PD 1/VEGF bispecific antibody, versus FOLFOX as second line therapy for locally advanced or metastatic biliary tract cancers

France

Therapeutic exploratory (Phase II) EU CTIS Study details

AMG 193 in Combination with Other Therapies in Subjects with Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous MTAP-deletion – Master Protocol

Denmark, Greece, France, Germany, Belgium, Spain +2 more

Human Pharmacology (Phase I)- Other EU CTIS Study details

A phase 1/1b/2 study evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of AMG 193 alone and in combination with docetaxel in subjects with advanced MTAP-null solid tumors

Belgium, Germany, Austria, France

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

PHASE 1/2, OPEN-LABEL, MULTICENTER, FIRST IN-HUMAN STUDY OF DS-3939a IN SUBJECTS WITH ADVANCED SOLID TUMORS

France, Spain, Belgium

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Biliary Cancer trials by city

Biliary Cancer in Toronto Biliary Cancer in Vancouver Biliary Cancer in Montreal Biliary Cancer in Calgary Biliary Cancer in Edmonton Biliary Cancer in Ottawa Biliary Cancer in Winnipeg Biliary Cancer in Quebec City Biliary Cancer in Hamilton Biliary Cancer in Kitchener Biliary Cancer in London Biliary Cancer in Halifax Biliary Cancer in New York Biliary Cancer in Los Angeles Biliary Cancer in Chicago Biliary Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease